Idarucizumab for a traumatic head injury patient taking dabigatran

BACKGROUND: Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan. We present a case of intracranial hemorrhage in a traumatic brain injury patient taking dabigatran who was trea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Emerg Med
Autores principales: Maruyama, Shuhei, Hayakawa, Koichi, Kanayama, Shuji, Iwamura, Hiromu, Wada, Daiki, Saito, Fukuki, Nakamori, Yasushi, Kuwagata, Yasuyuki
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2018
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6326148/
https://ncbi.nlm.nih.gov/pubmed/31179930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12245-018-0202-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares